NRIX Operating Cash Flow Growth
Nurix Therapeutics Inc · Operating Cash Flow Growth
NRIX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported264.64%period ending
NRIX TTM Cash from Operations YoY % (-113.31% → 264.64%)
Year-over-year change
High-resolution chart · PNG
NRIX operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 264.6434% | |
| -36.4948% | |
| -35.7667% | |
| -44.547% | |
| -137.1572% | |
| -123.9084% | |
| -156.091% | |
| -112.1109% | |
| 33.4671% | |
| 36.4351% | |
| 54.8002% | |
| 49.0855% | |
| 4.4212% | |
| -10.8168% | |
| -22.6445% | |
| -89.4233% | |
| -106.6152% | |
| -172.2822% | |
| -309.2488% | |
| -105,356.25% | |
| -1,065.9786% | |
| -199.8764% | |
| -164.382% | |
| -113.3111% |